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Summary: Human serum glycoproteins can be classified into those containing N-acetyl-D-galactosamine and into
those lacking this hexosamine. The N-acetyl-D-galactosamine-containing serum glycoproteins have alkali-labile chains
containing this hexosamine linked 0-glycosidically to hydroxy amino acids. These alkali-labile chains can be demon-
strated in neuraminic acid free serum glycoproteins by gas liquid chromatography and by using precipitating lectins
from invertebrates and plants. They are represented by two chains, one containing only N-acetyl-D-galactosamine,
the other with Z)-galactose linked (1—3) j3-glycosidically to this hexosamine forming a disaccharide. Scrologically
these two chains, which usually occur together on one molecule, can be characterized by their reaction with lectins
from Helix pomatia (anti-A like) and from Agaricus bisporus andArachis hypogaea (anti-TF specificity).
Immunchemische Untersuchungen an alkali-labilen Kohlenhydratketten menschlicher Serum-Glykoproteine
Zusammenfassung: Menschliche Serum-Glykoproteine kann man in zwei Gruppen einteilen, nämlich solche, welche
N-Acetyl-D-Galactosamin enthalten, und in solche, die dieses Hexosamin nicht besitzen. Die N-Acetyl-D-Galactosamin
enthaltenden Serum-Glykoproteine haben diesen Aminozucker 0-glykosidisch an Hydroxy-Aminosäuren gebunden.
Man kann diese alkali-labilen Ketten in neuraminsäure-freien Glykoproteinen des Serums nachweisen und zwar mit
Hilfe der Gaschromatographie und durch präzipitierende Lektine aus Invertebraten und Pflanzen. Sie bestehen aus
zwei Ketten-Typen, eine davon enthält nur N-Acetyl-£>-Galactosamin, während die andere noch £>-Galactose (1-3)
0-glykosidisch an dieses Hexosamin gebunden besitzt, so daß ein Disaccharid entsteht. Serologisch können diese
beiden Ketten, die in der Regel gemeinsam auf einem Molekül vorkommen, durch ihre Reaktionen mit den Lektinen
aus Helix pomatia (Anti-A ähnlich) und denen ms Agaricus bisporus undArachis hypogaea (Anti-TF Spezifität)
charakterisiert werden.
Introduction reacts with the lectins from Arachis hypogaea (peanut
receptor or TF-antigen) and Agaricus bisporus, whereas
In foregoing papers of this series concerning the chemical chain u reacts ̂  fte Qne frQm ̂ // pomaüa (the
structure and the serological role of human asialo serum so-called 4A-like' receptor) (2).
dycoprotein oligo-saccharide chains, we have already
investigated and described: In continuing this work, which has been undertaken and
planned in order to investigate the contribution of the
1. The reaction of neuraminic acid-free serum glyco- different carbohydrate chains to the 'liver clearance"
proteins with various, mainly anti-0-jD-galactosyl and metabolism of asialo glycoproteins as suggested by
specific lectins (1). Ashwell (3, 4), we have now focussed our research on the
following problems, the results of which we will discuss
2. The fact that some of these lectin receptors are
identical with two alkali-labile bound carbohydrate
chains: Chain I consisting of the disaccharide ß-D- a) The distribution of alkali-stable and alkali-labile carbo-
galactosyl-(l-3)-N-acetyl-/)-galactosamine, and hydrate chains within the group of serum glyco·
chain II represented by -linked N-acetyl-Z)- proteins.
galactosamine. Both chains are bound 0-glycosidically b) jjie chemical characterisation of the alkali-labile
to serine or threonine of the protein backbone (2). chains I and II by gas-liquid chromatography and
3. These two chains could be clearly identified by their c) the serological confirmation of these data by using
specific reaction with special purified lectins: Chain I the specific lectins, mentioned already under point 3.
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Material and Methods
Material
Human serum glycoproteins were highly purified by Haupt et
al. and obtained from Behringwerke AG, Marburg (West
Germany).
Lectins: Their preparation is described in a previous paper (2).
Techniques
Gas liquid chromatography (GLC)
a) Analysis of hexoses and hexosamines
Glycoprotein samples (2-3 mg) were hydrolysed in 3 mol/1
HC1 at 100 °C for 4 hours. After adding 30 Mg erythritol as
an internal standard, the solution was "neutralized" by
AgNOa, the sediment was removed by centrifugation and
washed 3 times with distilled water. The combined super-
natant and washings were lyophilized and then reacetylated
by incubation with acetic anhydride for 16 h at room
temperature (5). After relyophilization the sample has to
stay in vacuo over CaCl2 for 24 h. In order to prepare the
samples for analysis in the gas-liquid Chromatograph, they
were trimethylsilylated for 30 min, as described by Sweeley
et al. (6), except we used hexamethyldisilazane and tri-
methylchlorosilane in the reaction mixture.
The data of the gas-liquid Chromatograph we used and the
condition of the analysis have been described in a previous
paper (7).
b) Analysis of the disaccharide
The glycoproteins were desialylated by mild acid hydrolysis
(incubation with 0.05 mol/1 H2SO4 for l h by 80 °C)
followed by alkaline borohydride treatment as performed
by Newman et al. (7). The disaccharide content of the
glycoproteins was assayed by GLC in the same way as the
monosaccharides, except that they were trimethylsilylated
for 2 h and chromatographed isothermally at 250 °C with
trehalose as an internal standard.
c) Estimation of alkali-labile bound N-acetyl-galactosamine
This procedure was performed analogous to the disaccharide
analysis by mild acid hydrolysis and subsequent alkaline
borohydride treatment, by which the N-acetyl-galactosamine
is converted into galactosaminitol, which can be detected
by GLC (temperature programme 125 °C - 230 °C, in-
creasing 4 °C/min), internal standard: instead of trehalose
erythritol.
Chemical analysis ofsialic acid
The sialic acid (N-acetyl-neuraminic acid) was estimated by
using ΒΐαΓ* orcinol reagent (8). N-acetyl-neuraminic acid was
taken as a standard.
Haemagglutination inhibition assay
The assay was performed by using the Cooke serial dilution
microtitre system (Cooke Instruments, Zollikon, Switzerland).
Red cells were treated with neuraminidase for this purpose and
desialylated serum glycoproteins were used. The latter was
achieved by incubating 5 mg/ml protein in saline with 50 μΐ
neuraminidase (500 units/ml, Behringwerke AG, Marburg) for
l h at 37 °C. The test red cells were made up to a 2% suspension
in saline (erythrocytes of group 0 were taken from a single,
"standard" person) after they had been treated with neuramini-
dase (200 μΐ neuraminidase to 20 ml 2% red cell suspension)
for l h at 37 °C and washed three times with saline.
The concentration of the lectins was prepared in such a way,
that a dilution of an agglutinatory dose of 1:4 still gave a good
clumping picture. The haemagglutination inhibition assay titer
was defined as the minimum amount of substance inhibiting
the agglutination of red cells by the lectin at an agglutinatory
dosis of 4.
Results
The rnonosaccharide analysis of all investigated serum
glycoproteins is listed in table 1. According to this
table one may classify serum glycoproteins into two
groups: one group containing N-^acetyl-D-galactosamine,
the other not. We could find no serological (lectins),
or gas Chromatographie evidence for the occurrence of
alkali-labile carbohydrate chains in the last group. By
definition, alkali-labile carbohydrate chains are linked
via N-acetyl-Z>-galactosamine either to serine or to
threonine 0-glycosidically; thus this last group does
not contain any alkali-labile carbohydrate chains and
was excluded from further experiments.
Accordingly, as has been outlined in figure 1, we
investigated only the first group of serum glycoproteins,
namely those containing Nracetyl-jD-galactosamine. As
shown by the presence of N-acetyl-jD-glucosamirie and
ZXmannose, typical markers for alkali-stable carbo-
hydrate chains, alkali-stable carbohydrate chains are
also formed in these glycoproteins.
The presence of alkali-labile carbohydrate chains I and
II was then verified by serological and chemical methods
in this class of glycoproteins. The results of our
experiments are documented in table 2 and 3. However
there is no true relationship between the total content
of N-acetyl-P-galactosamine and the quantity of the
same hexosamine as quantitatively detected in the two
alkali-labile chains. This mis-relation must be attributed
to the alkaline borohydride treatment of the glyco-
proteins, which leads to a sorcalled "peeling-reaction"
by more or less splitting N-acetyl-/)-galactQsamine
molecules into pieces, which can no longer be identified
by GLC (9,10, 11).
The results of our investigations (as shown in tables 2
and 3) can be summarized as follows:
1. Of the 32 human serum glycoproteins we investigated
only nine contain N-acetyl-Z>-galactosamine-containing
alkali-labile carbohydrate chains. In the native state,
these residues will be more or less or even completely,
substituted or serologically blocked by N-acetyl-
neuraminic acid (2). The other serum glycoproteins
do not contain such structures.
2. With the exception of o^HS-glycoprotein, all these
asialo-glycoproteins react with lectins from peanut,
Arachis hypogaea, in the precipitin reaction (2). In
the haemagglutination inhibition assay, fetuin,
j32-glycoprptein III and IgD do not exhibit any inhibi-
tion, obviously due to the small amount of the TF-
disaccharide chain I (see introduction), whereas in
the agar gel diffusion much higher concentrations can
be used and have been used (up to 5%). On the other
hand, the competing TF-receptor on the erythrocyte
surface, has been shown to have a much higher affinity
to the lectin than the few groups on the inhibitory
substance. Serological urireactivity may also be due to
steric or topochemical reasons.,.
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9, 5 Sfti-Gly coprotein
Haptoglobin
Thyroxin Binding Globulin




* Fetuin is taken from fetal calf serum
** Secretory component is taken from human





































































































































































































Only alkali-stable carbohydrate chains,
no chain I and II (table 1)
N-acetyl-/>-galactosamine-containing
Alkali-labile carbohydrate chains
(in addition to alkali-stable ones)
1. Chain I = TF-receptor
2. Chain II - 'A-like'-receptor










Fig. 1. Alkali-stable and alkali-labile carbohydrate chains of human serum glycoproteins.
" As can be deduced from table 2 and 3, all serum glycoproteins, with the exception of <*2HS-glycoprotcin and Ig D of the right
group have both types of alkalHabile chains.
J. Clin. Chem. Clin. Biochem. / Vol. 17,1979 / No. 1
32 Uhlenbruck, Reese, Vaith and Haupt: Studies on carbohydrate chains of human serum glycoproteins

















/32-Gly copro tein III
Ig D
Arachis Agaricus Arachis Agaricus Disaccharide-Content















































* Fetuin is taken from fetal calf serum
Structure suggested for the receptor of the lectins fiom Arachis hypogaea and Agaricus bisporus:
/J-D-galactosyl(l-3)-N-acetyl-^-galactosamine -» serine (threonine)










/32-Gly copro tein III
Ig D
I. Serology:
a) Haemagglutination- b) Precipitin-Reaction
Inhibition-Assay in Agar-Gel (2)































* Fetuin is taken from fetal calf serum
Structure suggested for the receptor of the lectin from Helix pomatia: a-N-acetyl-jD-galactosamine -» serine (threonine)
3. Only IgD and a2HS-glycoprotein have one type of
alkali-labile carbohydrate chain, namely the TF-
receptor (0-£>-galactosyl-(l -3)-N-acetyl-D-galactos-
amine) of chain I, whereas all the others also have
the chain II type, namely the 'A-like'-N-acetyl-jD-
galactosaminyl-receptor. Both chains can be detected
chemically by GLC and serologically by the precipitin
reaction or haemagglutination inhibition with specific
lectins: all three methods allow a clear cut characteriza-
tion and estimation of the alkali-labile carbohydrate
chains of serum glycoproteins.
Discussion
The classification of serum glycoproteins into two
groups, namely those with alkali-labile carbohydrate
chains and those lacking them, offers some new aspects
for the metabolism, secretion, turnover and the "liver
clearance" mechanism as postulated by Ashwell's
experiments {fig. 1). It not only contributes new
information on the biochemical structure of the carbo-
hydrate part of the different serum glycoproteins, but
it raises once again the question of .the biological role
of the sugar side chains.
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One important feature of these asialo carbohydrate
chains seems to be that they can be recognized by
membrane-integrated vertebrate lectins; these specific-
ally react with the 0-galactosyl end-groups, which are
normally hidden in a cryptic state (2). Our investigations
thus find a solid basis for further studies in this direction.
Experiments, which are already in progress, employ radio-
active labelled asialo glycoproteins as a means of following
their metabolism, their catabolism, their excretion and
their clearance by certain organs, for instance the liver.
They also represent a basis for answering the questions,
whether the subterminal or next sugars to the |3-galactosyl-
endgroups have any influence; and whether the anomeric
linkage, or the carbohydrate chain itself (alkali-labile or
alkali-stable) has anything to do with the vertebrate
lectin mediated trap mechanism of these glycosubstances.
Finally, they serve as a biological model for studying the
metabolism of other (e. g. membrane-bound and isolated
membrane glycoproteins) glycosubstances containing one
or both types of chains, or one or both of the alkali-
labile chains (I and II).
This may also be of great interest with respect to: the
trapping of neuraminidase-treated red cells; the "homing"
of lymphocytes; the metastases of tumor cells with such
a cryptic deletion of carbohydrates or asialo structures;
and the interpretation of certain rosette-formation
phenomena, in which glycoproteins may participate and
membrane lectins may play a role (12).
Knowledge about the structure and distribution of such
alkali-labile carbohydrate chains of type I and II, and
their different substitution by sialic acids, as reviewed
recently (13), must be regarded as the first step towards
the biological attitude of investigating their general or
special role in different glycosubstances, a spectrum
which reaches from the submaxillary mucins to the
antifreeze-glycoprotein of the antarctic fishes and to
the serum glycoproteins described here (13).
All these relationships, also with respect to the alkali-
stable carbohydrate chains, are summarized in figure 2,
which includes the biochemical and serological properties
of glycoproteins and their "homing" by liver membrane-
integrated lectins. Blocking and inhibition studies of the
latter will provide further information on the metabolism
of glycoproteins; such experiments may also be performed
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Fig. 2. Classification of glycoproteins with respect to their alkali-labile and alkali-stable carbohydrate chains.
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